相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial
Michael Wang et al.
LANCET (2018)
Concomitant high expression of Toll-like receptor (TLR) and B-cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma
Ariz Akhter et al.
HEMATOLOGICAL ONCOLOGY (2017)
The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-κB mutational status
Anna Vidal-Crespo et al.
HAEMATOLOGICA (2017)
UPDATED RESULTS OF A MULTICENTER PHASE I/IB STUDY OF TGR-1202 IN COMBINATION WITH IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY MCL OR CLL
M.S. Davids et al.
HEMATOLOGICAL ONCOLOGY (2017)
The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-κB mutational status
Anna Vidal-Crespo et al.
HAEMATOLOGICA (2017)
FNC efficiently inhibits mantle cell lymphoma growth
Yan Zhang et al.
PLOS ONE (2017)
Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma
Nakhle S. Saba et al.
BLOOD (2016)
Targeting protein kinase C in mantle cell lymphoma
Hilka Rauert-Wunderlich et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
CD4OL-CD40 signaling on B-cell lymphoma response to BTK inhibitors
Zhijian Sun et al.
CANCER RESEARCH (2016)
TG2 and NF-κB Signaling Coordinates the Survival of Mantle Cell Lymphoma Cells via IL6-Mediated Autophagy
Han Zhang et al.
CANCER RESEARCH (2016)
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
Jingjing Wu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Second-generation inhibitors of Bruton tyrosine kinase
Jingjing Wu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas
M. K. Bognar et al.
ONCOGENE (2016)
Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma
Katy Mastorci et al.
PLOS ONE (2016)
ASN002: A novel dual SYK/JAK inhibitor with strong antitumor activity
Sanjeeva Reddy et al.
CANCER RESEARCH (2015)
Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma
Jia Ruan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ibrutinib in Previously Treated Waldenstrom's Macroglobulinemia
Steven P. Treon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation
Nathalie Knies et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells
Vaclav Seda et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma
Ian W. Flinn et al.
BLOOD (2014)
A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)
Brad S. Kahl et al.
BLOOD (2014)
Unlocking New Therapeutic Targets and Resistance Mechanisms in Mantle Cell Lymphoma
Dolors Colomer et al.
CANCER CELL (2014)
Do mantle cell lymphomas have an 'Achilles heel'?
Nakhle Saba et al.
CURRENT OPINION IN HEMATOLOGY (2014)
Pharmacological and genomic profiling identifies NF-kappa B-targeted treatment strategies for mantle cell lymphoma
Rami Rahal et al.
NATURE MEDICINE (2014)
Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB
Yulia N. Demchenko et al.
ONCOTARGET (2014)
Toll-Like Receptor-4 Signaling in Mantle Cell Lymphoma Effects on Tumor Growth and Immune Evasion
Lijuan Wang et al.
CANCER (2013)
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
Michael L. Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma via manipulation of tissue transglutaminase activities
Hyun Joo Jung et al.
BLOOD (2012)
Mesalamine in the treatment and maintenance of remission of ulcerative colitis
Maggie Ham et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2012)
NF-kappa B signaling pathways regulated by CARMA family of scaffold proteins
Marzenna Blonska et al.
CELL RESEARCH (2011)
NF-κB/STAT3/PI3K signaling crosstalk in iMycEμ B lymphoma
Seong-Su Han et al.
MOLECULAR CANCER (2010)
Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFα/NF-κB signaling axis
Z. Zak et al.
LEUKEMIA (2010)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis et al.
NATURE (2010)
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
Lee A. Honigberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Akt-mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt
Dong Bai et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
MyD88 Adapter-like (Mal)/TIRAP Interaction with TRAF6 Is Critical for TLR2-and TLR4-mediated NF-κB Proinflammatory Responses
Brett Verstak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target
Saman Hewamana et al.
BLOOD (2008)
Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4
Hyung S. Youn et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma
Richard I. Fisher et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling
Masahiro Yamamoto et al.
NATURE IMMUNOLOGY (2006)
Allergen-induced peribronchial fibrosis and mucus production mediated by IκB kinase β-dependent genes in airway epithelium
DH Broide et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFβ signalling pathways
EG Rizzatti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-κB signaling pathway
MD Morrison et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides
B Jahrsdorfer et al.
CLINICAL CANCER RESEARCH (2005)
BCL10 mediates lipopolysaccharide/Toll-like receptor-4 signaling through interaction with Pellino2
YL Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Regulation of the NF-κB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation
GX Liao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Src-family kinases in B-cell development and signaling
SB Gauld et al.
ONCOGENE (2004)
Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma
H Kaufmann et al.
BLOOD (2004)
Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia
BD Smith et al.
BLOOD (2004)
The death domain kinase RIP1 is essential for tumor necrosis factor alpha signaling to p38 mitogen-activated protein kinase
TH Lee et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells
E Claudio et al.
NATURE IMMUNOLOGY (2002)
Essential role of MD-2 in LPS responsiveness and TLR4 distribution
Y Nagai et al.
NATURE IMMUNOLOGY (2002)
Genetic evidence for the essential role of β-transducin repeat-containing protein in the inducible processing of NF-κB2/p100
A Fong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells
RE Davis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Possible new role for NF-κB in the resolution of inflammation
T Lawrence et al.
NATURE MEDICINE (2001)
Activation of NF-κB by FADD, Casper, and caspase-8
WH Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
